Quarterly Business Update and Investor Calls
Highlights for the quarter ending September 2017
ASX Announcements
Appendix 4C – Quarterly Report
Appendix 4C – Quarterly Report
Notice of Annual General Meeting/Proxy Form
Notice of Annual General Meeting and Explanatory Statement
Annual Report to Shareholders
Annual Report For The Period Ended 30 June 20167
Appointments to the Management Team
Invitrocue announces appointments to the management team
Preliminary Final Report
Preliminary Final Report: Download here.
IVQ receives award from Singapore government IP office
IVQ receives award from Singapore government IP office
Investor Presentation
Investor Presentation
Appendix 4C – Quarterly Report and Business Update
Appendix 4C – Quarterly Report and Business Update Investor Call
Launch of New Joint Innovation Laboratory to Advance Personalised Medicine for Cancer Treatment
L-R: Dr Benjamin Seet, Executive Director of the Biomedical Research Council, A*STAR; His Excellency Bruce Gosper, the Australian High Commissioner to Singapore; Dr Steven Fang, Chief Executive Officer / Founder, Invitrocue Ltd; The Hon Martin Hamilton Smith, Minister for Trade and Investment, South Australian Government; Dr Raj Thampuran, Managing Director, A*STAR; Professor Ng Huck Hui, …